Chinese Small/Mid-cap Stocks Shine

Gene Linn |

“Developers would still have to deal with the fierce competition in sales and tight financial conditions themselves without any hope of policy help from the central government,” the brokerage said.

One of the few properties that BOCOM still rates a “Buy” is Shimao Property (0813.HK), a Shanghai-based company. “We think its sale performance was in-line with our expectation and the current valuation is still undervalued on the counter.” End

DAILY FIX -- Hong Kong Rally Continues

Hong Kong Blue Chips: +188, +1.0%, to 18,329, 10-12-11, Hang Seng Index

Chinese Stocks in Hong Kong: +198, +2.1% to 9,456, 10-12-11, HSCE Index

Shanghai Stocks: +3.0%, 2,420, 10-12-11, Shanghai Composite Index.

Chinese Stocks in the U.S.: +0.02, to 363.0, 10-11-11, Bank of New York Mellon, ADR Index-China

Insight: A strong rise in Chinese stock markets carried Hong Kong higher, extending its recent rally in moderately active trading. KGI Research

Quotable: "...the overall market sentiment was relatively strong. Particularly, 9-day RSI had already climbed back above 50 and the overall market turnover was relatively high to show the strength of the market. It might help the market to have better performance in short term." Core Pacific Yamaichi. 10-12-11

Chinese Companies to Watch: "Valuations of A-share and H-share banks have hit their historical low and deliver excellent mid-to long-term investment appeal, with H-share banks trading at only 5.42x P/E and 1.05x P/B on average. We maintain “Outperform” for the sector and recommend CCB (CICHY), MSB (CMAKY), CITIC Bank (CHCJY)...." BOCOM International. 10-11-11

Brokerages and analysts cited have disclaimers on their websites emphasizing their statements are for information only. They do not endorse my blog, and I don't endorse them.
For a list of Chinese companies sold in the U.S. and information on each company go to http://www.adrbnymellon.com/dr_country_profile.jsp?country=CN

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
BRF.PR.A:CA Brookfield Renewable Power Preferred Equity Inc. C 16.62 -0.08 -0.48 3,655

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

Lyft

Lyft matches drivers using their own personal vehicles with passengers who request rides through the smartphone app, and the passengers pay automatically through the app. When using Lyft, passengers have…